Swahili
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
14 matokeo
Method for the control of shipping fever pneumonia in cattle
Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
SUMMARY OF THE INVENTION
Shipping fever is generally recognized, by those involved in the beef cattle industry, as the disease responsible for a major portion of the economic losses encountered in the production and handling of cattle. The syndrome is characterized clinically by fever, acute
Compositions and treatments for pneumonia in animals
Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
TECHNICAL FIELD
The present invention relates generally to subunit antigens, vaccine compositions, and methods of administering the same. More particularly, the present invention relates to Pasteurella haemolytica proteins for use in stimulating immunity against pneumonia.
BACKGROUND OF THE
Nucleic acid probes for the detection of bacteria of the genus Legionella and methods for the detection of the etiological agents of Legionnaires' disease
Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
This invention relates to nucleic acids, probes, kits, and methods for the detection of pathogenic organisms, including Legionella sp., believed to be involved with Legionnaire's disease, Pontiac fever, Pittsburgh pneumonia, and several other diseases.
BACKGROUND OF THE INVENTION
Legionella were
Veterinary pharmaceutical method of administration
Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
Not applicable.
REFERENCE TO A MICROFICHE APPENDIX
Not applicable.
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates, generally to veterinary pharmaceutical and feed supplement compositions and to
Veterinary pharmaceutical composition
Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
Not applicable.
REFERENCE TO A MICROFICHE APPENDIX
Not applicable.
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates, generally to veterinary pharmaceutical and feed supplement compositions and to
Veterinary pharmaceutical composition
Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
Not applicable.
REFERENCE TO A MICROFICHE APPENDIX
Not applicable.
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates, generally to veterinary pharmaceutical and feed supplement compositions and to
Veterinary pharmaceutical composition and method of administration
Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
BACKGROUND OF THE INVENTION
1. Field of the Invention.
The present invention relates, generally to veterinary pharmaceutical and feed supplement compositions and methods of administering them. More particularly, the invention relates to a composition of calcium, B-vitamins and propylene glycol and a
Veterinary treatment
Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
This invention relates to a method for the treatment of bacterial infections in pigs, particularly those infections associated with farrowing fever and bacterial pneumonia.
GB-B-2 005 538 describes a dry pharmaceutical composition, which comprises 20 mg to 1500 mg of amoxycillin trihydrate, 20 mg to
Interleukin-2-leukotoxin gene fusions and uses thereof
Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
DESCRIPTION
1. Technical Field
The present invention relates generally to subunit antigens, vaccine compositions, and methods of administering the same. More particularly, the present invention relates to an interleukin-2-leukotoxin gene fusion product and the use of the same for stimulating
Gamma-iterferon-leukotoxin gene fusions and uses thereof
Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
DESCRIPTION
1. Technical Field
The present invention relates generally to subunit antigens, vaccine compositions, and methods of administering the same. More particularly, the present invention relates to cytokine-leukotoxin gene fusion products and the use of the same for stimulating immunity
Vaccines with chimeric protein comprising gamma-interferon and leukotoxin derived from pasteurella haemolytica
Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
DESCRIPTION
TECHNICAL FIELD
The present invention relates generally to subunit antigens, vaccine compositions, and methods of administering the same. More particularly, the present invention relates to cytokine-cytotoxin gene fusion products and the use of the same for stimulating immunity against
Chimeric protein comprising an RTX-family cytotoxin and interferon-2 or interferon
Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
DESCRIPTION
1. Technical Field
The present invention relates generally to subunit antigens, vaccine compositions, and methods of administering the same. More particularly, the present invention relates to cytokine-cytotoxin gene fusion products and the use of the same for stimulating immunity
Pasteurella haemolytica leukotoxin compositions and uses thereof
Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
TECHNICAL FIELD
The present invention relates generally to subunit antigens, vaccine compositions, and methods of administering the same. More particularly, the present invention relates to Pasteurella haemolytica proteins for use in stimulating immunity against pneumonia.
BACKGROUND OF THE
Leukotoxin vaccine compositions and uses thereof
Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
TECHNICAL FIELD
The present invention relates generally to subunit antigens, vaccine compositions, and methods of administering the same. More particularly, the present invention relates to Pasteurella haemolytica proteins for use in stimulating immunity against pneumonia.
BACKGROUND OF THE
Hifadhidata kamili ya mimea ya dawa inayoungwa mkono na sayansi
- Inafanya kazi katika lugha 55
- Uponyaji wa mitishamba unaungwa mkono na sayansi
- Kutambua mimea kwa picha
- Ramani ya GPS inayoshirikiana
- Soma machapisho ya kisayansi yanayohusiana na utafutaji wako
- Tafuta mimea ya dawa na athari zao
- Panga maslahi yako na fanya tarehe ya utafiti wa habari, majaribio ya kliniki na ruhusu
Andika dalili au ugonjwa na usome juu ya mimea ambayo inaweza kusaidia, chapa mimea na uone magonjwa na dalili ambazo hutumiwa dhidi yake.
* Habari zote zinategemea utafiti wa kisayansi uliochapishwa
